GlassScriptPhysician profile
Laina Koryakos
NPI 1447979356
$1,828.88
in general payments reported to CMS, 2019-2025
26 companies · $554 in 2025
The $554 reported for 2025 was more than what a typical Medical provider received nationally (typical 2025 total: $213).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $540 · 2024: $735 · 2025: $554.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,804 · Education: $25.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,803.88 |
| Education | $25.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $325.56 | 2023-2024 | Inceptiv, Kyphon Express II Kyphopak Tray, Intellis Adaptivestim |
| Astrazeneca Pharmaceuticals LP | $322.32 | 2023-2025 | Farxiga, Airsupra, Breztri |
| Spinal Simplicity, LLC | $145.59 | 2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $138.77 | 2023 | Watchman Flx |
| Novo Nordisk INC | $120.30 | 2023-2025 | Ozempic, Rybelsus |
| Currax Pharmaceuticals LLC | $100.02 | 2023-2025 | Contrave, Nexletol, Nexlizet |
| Abbvie INC. | $69.19 | 2024 | |
| Pfizer INC. | $65.04 | 2024-2025 | |
| Protega Pharmaceutials INC | $64.92 | 2025 | Roxybond |
| Exact Sciences Corporation | $57.72 | 2024-2025 | Cologuard Collection Kit |
| Myriad Women'S Health, INC. | $50.19 | 2023 | Myrisk |
| Abbott Laboratories | $48.18 | 2023 | Freestyle Libre 2, Freestyle Libre |
| Lilly USA, LLC | $42.63 | 2023 | Mounjaro, Jardiance |
| Glaxosmithkline, LLC. | $36.93 | 2024 | Trelegy Ellipta, Shingrix |
| Inspire Medical Systems, INC. | $33.10 | 2025 | Inspire |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $30.49 | 2025 | Dexcom G6 Transmitter |
| Pacira Pharmaceuticals Incorporated | $27.16 | 2024 | Iovera |
| Bioventus LLC | $20.23 | 2024 | Supartz Fx Sodium Hyaluronate |
| Corcept Therapeutics | $18.75 | 2024 | Korlym |
| Foundation Fusion Solutions, LLC | $17.59 | 2025 | |
| Kowa Pharmaceuticals America, INC. | $16.88 | 2025 | Zoryve |
| Vertex Pharmaceuticals Incorporated | $16.84 | 2025 | |
| Amgen INC. | $16.82 | 2025 | Evenity |
| Axsome Therapeutics, INC. | $16.49 | 2024 | Auvelity |
| Averitas Pharma INC. | $14.15 | 2025 | Qutenza |
| Cook Medical LLC | $13.02 | 2023 | Cook |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Laina Koryakos listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.